4//SEC Filing
Mateus Fernando 4
Accession 0001415889-22-001741
CIK 0000001800other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 8:21 PM ET
Size
11.8 KB
Accession
0001415889-22-001741
Insider Transaction Report
Form 4
Mateus Fernando
Senior Vice President
Transactions
- Tax Payment
Common shares without par value
2022-02-21$116.79/sh−701$81,870→ 17,846 total - Tax Payment
Common shares without par value
2022-02-22$116.79/sh−886$103,476→ 16,960 total - Award
Option (right to buy)
2022-02-18+48,852→ 48,852 totalExercise: $117.58From: 2023-02-18Exp: 2032-02-17→ Common Shares (48,852 underlying) - Tax Payment
Common shares without par value
2022-02-19$116.79/sh−595$69,490→ 18,547 total - Award
Common shares without par value
2022-02-18+10,482→ 19,142 total
Footnotes (2)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 16,284 on February 18, 2023, 16,284 on February 18, 2024, and 16,284 on February 18, 2025.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001895703
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 8:21 PM ET
- Size
- 11.8 KB